Gordon T. McInnes

19.6k total citations · 5 hit papers
123 papers, 13.4k citations indexed

About

Gordon T. McInnes is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Gordon T. McInnes has authored 123 papers receiving a total of 13.4k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Cardiology and Cardiovascular Medicine, 51 papers in Endocrinology, Diabetes and Metabolism and 27 papers in Surgery. Recurrent topics in Gordon T. McInnes's work include Blood Pressure and Hypertension Studies (80 papers), Hormonal Regulation and Hypertension (44 papers) and Heart Rate Variability and Autonomic Control (16 papers). Gordon T. McInnes is often cited by papers focused on Blood Pressure and Hypertension Studies (80 papers), Hormonal Regulation and Hypertension (44 papers) and Heart Rate Variability and Autonomic Control (16 papers). Gordon T. McInnes collaborates with scholars based in United Kingdom, United States and Norway. Gordon T. McInnes's co-authors include Sverre E. Kjeldsen, Peter Sever, Mark J. Caulfield, Neil R Poulter, Eoin OʼBrien, Hans Wedel, Jesper Mehlsen, Markku S. Nieminen, Rory Collins and Arni Kristinsson and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Diabetes Care.

In The Last Decade

Gordon T. McInnes

120 papers receiving 12.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial

2003 2.7k citations Peter Sever, Mark J. Caulfield et al. The Lancet profile →
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial

2005 1.9k citations Peter Sever, Mark J. Caulfield et al. The Lancet profile →
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial

2004 1.8k citations Stevo Julius, Sverre E. Kjeldsen et al. The Lancet profile →
Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial

2015 735 citations Bryan Williams, Thomas M. MacDonald et al. The Lancet profile →
British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary

2004 591 citations Bryan Williams, Morris J. Brown et al. profile →

Peers

Countries citing papers authored by Gordon T. McInnes

Since Specialization

Citations

This map shows the geographic impact of Gordon T. McInnes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gordon T. McInnes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gordon T. McInnes more than expected).

Fields of papers citing papers by Gordon T. McInnes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gordon T. McInnes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gordon T. McInnes. The network helps show where Gordon T. McInnes may publish in the future.

Co-authorship network of co-authors of Gordon T. McInnes

This figure shows the co-authorship network connecting the top 25 collaborators of Gordon T. McInnes. A scholar is included among the top collaborators of Gordon T. McInnes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gordon T. McInnes. Gordon T. McInnes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Contrasting mortality risks among subgroups of treated hypertensive patients developing new-onset diabetes 2015 ·European Heart Journal ·Stefanie Lip, Panniyammakal Jeemon, Linsay McCallum, Anna F. Dominiczak, Gordon T. McInnes, Sandosh Padmanabhan	19
2	Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial breakdown → 2015 ·The Lancet ·Bryan Williams, Thomas M. MacDonald, S. V. Morant, David R. Webb, Peter Sever, Gordon T. McInnes, Ian Ford, J. CRUICKSHANK, Mark J. Caulfield, Jackie Salsbury, Isla S. Mackenzie, Sandosh Padmanabhan, Morris J. Brown	735
3	Noninvasive Cardiac Event Monitoring to Detect Atrial Fibrillation After Ischemic Stroke 2013 ·Stroke ·Peter Higgins, Peter W. Macfarlane, Jesse Dawson, Gordon T. McInnes, Peter Langhorne, Kennedy R. Lees	84
4	A double-blind, randomized study comparing the antihypertensive effect of eplerenone and spironolactone in patients with hypertension and evidence of primary aldosteronism 2011 ·Journal of Hypertension ·Hari Parthasarathy, Joël Ménard, William B. White, William F. Young, Gordon H. Williams, Bryan Williams, Luís M. Ruilope, Gordon T. McInnes, John Connell, Thomas M. MacDonald	177
5	Resting Heart Rate Pattern During Follow-Up and Mortality in Hypertensive Patients 2009 ·Hypertension ·Laura Paúl, Claire E. Hastie, (unknown), (unknown), Scott Muir, John Connell, Anna F. Dominiczak, Gordon T. McInnes, Sandosh Padmanabhan	101
6	Clinical pharmacology and therapeutics of hypertension 2008 ·Elsevier eBooks ·Gordon T. McInnes	5
7	Progressive effects of valsartan compared with amlodipine in prevention of diabetes according to categories of diabetogenic risk in hypertensive patients: The VALUE trial 2008 ·Blood Pressure ·Sverre E. Kjeldsen, Gordon T. McInnes, Giuseppe Mancia, Tsushung A. Hua, Stevo Julius, Michael A. Weber, António Coca, Xavier Girerd, Kenneth Jamerson, Pierre Larochelle, Thomas M. MacDonald, Roland E. Schmieder, M. Anthony Schork, Reuven J. Viskoper, J Widimský, Alberto Zanchetti, (unknown)	10
8	Angiotensin-II receptor blockers: benefits beyond blood pressure reduction? 2005 ·Journal of Human Hypertension ·Massimo Volpe, Luís M. Ruilope, Gordon T. McInnes, Bernard Waeber, Michael A. Weber	41
9	Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial 2004 ·The Lancet ·Michael A. Weber, Stevo Julius, Sverre E. Kjeldsen, Hans R. Brunner, Steffan Ekman, Lennart Hansson, Tsushung A. Hua, John H. Laragh, Gordon T. McInnes, Lada Mitchell, Francis Plat, M. Anthony Schork, Beverly A. Smith, Alberto Zanchetti	428
10	Characteristics of 15314 Hypertensive Patients at High Coronary Risk. The VALUE Trial 2001 ·Blood Pressure ·Sverre E. Kjeldsen, Stevo Julius, Hans R. Brunner, Lennart Hansson, Marc Henis, Steffan Ekman, John H. Laragh, Gordon T. McInnes, Beverly A. Smith, Michael A. Weber, Alberto Zanchetti	67
11	A NATIONAL PANEL FOR RESEARCH INTEGRITY: 2001 ·The Journal of the Royal College of Physicians of Edinburgh ·Peter Stonier, Gordon Lowe, Gordon T. McInnes, J A Murie, (unknown), (unknown)	1
12	Angiotensin II Antagonism in Clinical Practice: Experience with Valsartan 1999 ·Journal of Cardiovascular Pharmacology ·Gordon T. McInnes	16
13	Clinical Advantage of Valsartan 1999 ·Cardiology ·Gordon T. McInnes	18
14	Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer? 1998 ·The Lancet ·Anthony F. Lever, David Hole, C. Gillis, (unknown), Gordon T. McInnes, (unknown), Peter Meredith, Lilian S. Murray, John L. Reid, James W.K. Robertson	462
15	Hypertension and coronary artery disease: cause and effect 1995 ·Journal of Hypertension ·Gordon T. McInnes	24
16	Severe mesenteric ischemia due to primary thrombocythemia treated with prostacyclin 1990 ·Critical Care Medicine ·(unknown), Gordon T. McInnes, (unknown), (unknown)	0
17	Comparison of enalapril and atenolol in mild to moderate hypertension 1989 ·The American Journal of Medicine ·Ariane L. Herrick, Patrick Waller, (unknown), Stuart D. Pringle, John S. Callender, (unknown), (unknown), Gordon Murray, John L. Reid, (unknown), (unknown), H A Carmichael, James I. Robertson, Stephen G. Ball, Gordon T. McInnes	40
18	Drug Interactions that Matter 1988 ·Drugs ·Gordon T. McInnes, (unknown)	81
19	Dose-response relationships for spironolactone at steady state 1982 ·Clinical Pharmacology & Therapeutics ·Gordon T. McInnes, (unknown), John Shelton, I. Harrison	5
20	Relative potency of amiloride and spironolactone in healthy man 1982 ·Clinical Pharmacology & Therapeutics ·Gordon T. McInnes	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact